Modella Ai Announces Agreement to Accelerate Ai-Driven Oncology Clinical Development

Modella AI and AstraZeneca Partner to Accelerate Oncology Trials - AI-Tech Park

Modella AI, a leader in artificial intelligence for life sciences, today announced a multi-year agreement with AstraZeneca. Under the agreement, Modella AI will provide access to its state-of-the-art multi-modal AI foundation models to AstraZeneca. This agreement aims to harness Modella AI’s advanced foundation models, capable of rich feature extraction from diverse data types, to accelerate clinical development across AstraZeneca’s global oncol…